Skip to main
University-wide Navigation

BH WELL’s Research Brief series showcases our teams’ most up-to-date research and evidence-based practice in a concise, digestible format. Each research summary serves to bridge the gap between clinical research and public knowledge by enhancing communication, supporting advocacy efforts, and facilitating translation amongst all mental healthcare workers. Providing key insights from evidence-based research will help inform public understanding of health issues, empower individuals to make informed decisions, and to promote overall healthier behaviors/outcomes.

Volume 1: 2024

Volume 2: 2025

Current Issue

Assessing the impact of long-acting injectable compared to oral antipsychotic medications on readmission to a state psychiatric hospital

Volume 2, Issue 8

December 2025

Closing the Gap: Individuals with serious mental illness such as schizophrenia spectrum disorder often have high mortality rates that can be associated with poor medication adherence. This study examined whether the use of long-acting injectable (LAI) antipsychotics may improve medication adherence and reduce hospitalizations.

  

Promoting Positive Patient Outcomes: Previous studies indicate that patients treated with LAIs have significantly lower readmission rates and improved recovery outcomes than those prescribed oral antipsychotics. 

  

Optimizing Resources: This low-cost study examined patient records to compare rehospitalization rates among patients discharged with an LAI versus oral antipsychotics.